![](/img/cover-not-exists.png)
Cost-Effectiveness of Vemurafenib as a First-Line Treatment in Patients with Braf V600 Mutation-Positive Unresectable or Metastatic Melanoma in Spain
Rubio-Terrés, C, Orofino, J, Armas, J, Parra, J, Rubio-Rodríguez, D, Grau, SVolume:
18
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.09.1148
Date:
November, 2015
File:
PDF, 52 KB
english, 2015